Jamp Gefitinib 250 mg (Gefitinib TABLET) 250 MG

JAMP Gefitinib 250 mg tablets are a pharmaceutical product used for targeted therapy. This oral medication is designed to interact with specific proteins in the body, often used in cancer treatment protocols.

Strength

250 MG

Manufacturer / TM Owner

JAMP PHARMA CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JAMP Gefitinib 250 mg tablets are primarily used in targeted therapy, often for certain types of cancer. The active ingredient, gefitinib, works by inhibiting specific proteins that can contribute to cancer cell growth. This medication is typically prescribed as part of a broader treatment plan, determined by healthcare professionals based on individual patient needs.

Side Effects

Common effects of JAMP Gefitinib 250 mg tablets may include gastrointestinal issues such as diarrhea or nausea. Some users might experience skin reactions or changes in appetite. It's important to monitor any side effects and consult with a healthcare provider if they become severe or persistent.

Precautions & Warnings

JAMP Gefitinib 250 mg tablets should be handled with care, following the guidance of a healthcare professional. It's crucial to inform your doctor about any pre-existing conditions or allergies before starting this medication. Proper storage and adherence to prescribed usage are essential for safety and effectiveness.

Avoid Interactions

JAMP Gefitinib 250 mg tablets may interact with certain medications, including those that affect liver enzymes. It's important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also impact the effectiveness and safety of this medication.

Frequently Asked Questions

JAMP Gefitinib 250 mg tablets are used in targeted therapy, often for certain types of cancer. The active ingredient, gefitinib, works by inhibiting specific proteins that can contribute to cancer cell growth.

JAMP Gefitinib 250 mg tablets are taken orally, typically as prescribed by a healthcare professional. It's important to follow the dosage and administration instructions provided.

Common side effects may include gastrointestinal issues such as diarrhea or nausea, as well as skin reactions and changes in appetite.

JAMP Gefitinib 250 mg may interact with certain medications, so it's important to discuss all current medications with a healthcare provider.

Precautions include informing your doctor about any pre-existing conditions or allergies, proper storage, and adhering to prescribed usage.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.